195 related articles for article (PubMed ID: 31172885)
1. How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study.
Morin L; Wastesson JW; Laroche ML; Fastbom J; Johnell K
Palliat Med; 2019 Sep; 33(8):1080-1090. PubMed ID: 31172885
[TBL] [Abstract][Full Text] [Related]
2. Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia.
Morin L; Vetrano DL; Grande G; Fratiglioni L; Fastbom J; Johnell K
J Am Med Dir Assoc; 2017 Jun; 18(6):551.e1-551.e7. PubMed ID: 28431913
[TBL] [Abstract][Full Text] [Related]
3. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus.
Morin L; Laroche ML; Vetrano DL; Fastbom J; Johnell K
Eur J Clin Pharmacol; 2018 Oct; 74(10):1333-1342. PubMed ID: 29934849
[TBL] [Abstract][Full Text] [Related]
4. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.
Morin L; Vetrano DL; Rizzuto D; Calderón-Larrañaga A; Fastbom J; Johnell K
Am J Med; 2017 Aug; 130(8):927-936.e9. PubMed ID: 28454668
[TBL] [Abstract][Full Text] [Related]
5. Drug consumption and futile medication prescribing in the last year of life: an observational study.
Curtin D; O'Mahony D; Gallagher P
Age Ageing; 2018 Sep; 47(5):749-753. PubMed ID: 29688246
[TBL] [Abstract][Full Text] [Related]
6. Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
Morin L; Todd A; Barclay S; Wastesson JW; Fastbom J; Johnell K
Cancer; 2019 Jul; 125(13):2309-2317. PubMed ID: 30906987
[TBL] [Abstract][Full Text] [Related]
7. Prescribing and deprescribing in older people with life-limiting illnesses receiving hospice care at the end of life: A longitudinal, retrospective cohort study.
Alwidyan T; McCorry NK; Black C; Coulter R; Forbes J; Parsons C
Palliat Med; 2024 Jan; 38(1):121-130. PubMed ID: 38032069
[TBL] [Abstract][Full Text] [Related]
8. Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia.
Matlow JN; Bronskill SE; Gruneir A; Bell CM; Stall NM; Herrmann N; Seitz DP; Gill SS; Austin PC; Fischer HD; Fung K; Wu W; Rochon PA
J Am Geriatr Soc; 2017 Jul; 65(7):1535-1542. PubMed ID: 28369696
[TBL] [Abstract][Full Text] [Related]
9. Deprescription in Advanced Cancer Patients Referred to Palliative Care.
Oliveira L; Ferreira MO; Rola A; Magalhães M; Ferraz Gonçalves J
J Pain Palliat Care Pharmacother; 2016 Sep; 30(3):201-5. PubMed ID: 27491473
[TBL] [Abstract][Full Text] [Related]
10. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.
Lavan AH; Gallagher P; Parsons C; O'Mahony D
Age Ageing; 2017 Jul; 46(4):600-607. PubMed ID: 28119312
[TBL] [Abstract][Full Text] [Related]
11. Potential overtreatment in end-of-life care in adults 65 years or older dying from cancer: applying quality indicators on nationwide registries.
Szilcz M; Wastesson JW; Morin L; Calderón-Larrañaga A; Lambe M; Johnell K
Acta Oncol; 2022 Dec; 61(12):1437-1445. PubMed ID: 36495144
[TBL] [Abstract][Full Text] [Related]
12. Is the level of education associated with transitions between care settings in older adults near the end of life? A nationwide, retrospective cohort study.
Kelfve S; Wastesson J; Fors S; Johnell K; Morin L
Palliat Med; 2018 Feb; 32(2):366-375. PubMed ID: 28952874
[TBL] [Abstract][Full Text] [Related]
13. Potentially inappropriate medication in primary care at the end of life: a mixed-method study.
Pype P; Mertens F; Helewaut F; D'Hulster B; De Sutter A
Acta Clin Belg; 2018 Jun; 73(3):213-219. PubMed ID: 29199905
[TBL] [Abstract][Full Text] [Related]
14. End-of-life care during and after an acute hospitalization in older patients with cancer, end-stage organ failure, or frailty: A sub-analysis of a prospective cohort study.
Huijberts S; Buurman BM; de Rooij SE
Palliat Med; 2016 Jan; 30(1):75-82. PubMed ID: 26376937
[TBL] [Abstract][Full Text] [Related]
15. Access to palliative care by disease trajectory: a population-based cohort of Ontario decedents.
Seow H; O'Leary E; Perez R; Tanuseputro P
BMJ Open; 2018 Apr; 8(4):e021147. PubMed ID: 29626051
[TBL] [Abstract][Full Text] [Related]
16. Potentially inappropriate prescribing in a population of frail elderly people.
Récoché I; Lebaudy C; Cool C; Sourdet S; Piau A; Lapeyre-Mestre M; Vellas B; Cestac P
Int J Clin Pharm; 2017 Feb; 39(1):113-119. PubMed ID: 27942948
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Palliative Care Delivery in the Last Year of Life Between Adults With Terminal Noncancer Illness or Cancer.
Quinn KL; Wegier P; Stukel TA; Huang A; Bell CM; Tanuseputro P
JAMA Netw Open; 2021 Mar; 4(3):e210677. PubMed ID: 33662135
[TBL] [Abstract][Full Text] [Related]
18. Inter-rater reliability of STOPPFrail [Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy] criteria amongst 12 physicians.
Lavan AH; Gallagher P; O'Mahony D
Eur J Clin Pharmacol; 2018 Mar; 74(3):331-338. PubMed ID: 29159488
[TBL] [Abstract][Full Text] [Related]
19. Can primary palliative care education change life-sustaining treatment intensity of older adults at the end of life? A retrospective study.
Liu Q; Qin M; Zhou J; Zheng H; Liu W; Shen Q
BMC Palliat Care; 2021 Jun; 20(1):84. PubMed ID: 34154579
[TBL] [Abstract][Full Text] [Related]
20. Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France.
Morin L; Beaussant Y; Aubry R; Fastbom J; Johnell K
J Am Geriatr Soc; 2016 Sep; 64(9):1851-7. PubMed ID: 27459579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
